Delayed Effect of Dendritic Cells Vaccination on Survival in Glioblastoma: A Systematic Review and Meta-Analysis

Background: Dendritic cell vaccination (DCV) strategies, thanks to a complex immune response, may flare tumor regression and improve patients’ long-term survival. This meta-analysis aims to assess the efficacy of DCV for newly diagnosed glioblastoma patients in clinical trials. Methods: The study da...

Deskribapen osoa

Xehetasun bibliografikoak

Egile Nagusiak:	Salvatore Cozzi, Masoumeh Najafi, Marzieh Gomar, Patrizia Ciammella, Cinzia Iotti, Corrado Iaccarino, Massimo Dominici, Giacomo Pavesi, Chiara Chiavelli, Ali Kazemian, Amin Jahanbakhshi
Formatua:	Artigo
Hizkuntza:	Inglês
Argitaratua:	MDPI AG 2022-02-01
Saila:	Current Oncology
Gaiak:	glioblastoma immunotherapy dendritic cell vaccination checkpoint inhibitor survival
Sarrera elektronikoa:	https://www.mdpi.com/1718-7729/29/2/75
Etiketak:	Etiketa erantsi Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!